{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:39:40Z","timestamp":1788262780268,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2016058401"],"award-info":[{"award-number":["2016058401"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBSI14B1Z1"],"award-info":[{"award-number":["RBSI14B1Z1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015256","name":"Floriculture Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["April16\/848-791"],"award-info":[{"award-number":["April16\/848-791"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nbd.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T02:35:42Z","timestamp":1557887742000},"page":"79-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"129","author":[{"given":"Tiziana","family":"Bonifacino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gallia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0803-1042","authenticated-orcid":false,"given":"Silvia","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Torazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldamaria","family":"Puliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludo","family":"Van Den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giambattista","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Milanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"46","key":"10.1016\/j.nbd.2019.05.007_bb0005","doi-asserted-by":"crossref","first-page":"15244","DOI":"10.1523\/JNEUROSCI.1918-14.2014","article-title":"Reversible behavioral phenotypes in a conditional mouse model of tdp-43 proteinopathies","volume":"34","author":"Alfieri","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.05.007_bb0010","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"11","key":"10.1016\/j.nbd.2019.05.007_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical genetics of amyotrophic lateral sclerosis: what do we really know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/nbdi.1999.0237","article-title":"Differential expression of group I metabotropic glutamate receptors in rat spinal cord somatic and autonomic motoneurons: possible implications for the pathogenesis of amyotrophic lateral sclerosis","volume":"6","author":"Anneser","year":"1999","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00001756-200402090-00012","article-title":"Differential expression of mGluR5 in human lumbosacral motoneurons","volume":"15","author":"Anneser","year":"2004","journal-title":"Neuroreport."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0306-4522(01)00181-6","article-title":"Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes","volume":"105","author":"Aronica","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2019.05.007_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2018.02.007","article-title":"Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications","volume":"38","author":"Battaglia","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"43","key":"10.1016\/j.nbd.2019.05.007_bb0040","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1073\/pnas.0607423103","article-title":"Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis","volume":"103","author":"Beers","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5778","key":"10.1016\/j.nbd.2019.05.007_bb0045","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science."},{"key":"10.1016\/j.nbd.2019.05.007_bb0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nbd.2016.07.011","article-title":"Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease","volume":"95","author":"Bonifacino","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.05.007_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuropharm.2017.06.020","article-title":"In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"123","author":"Bonifacino","year":"2017","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.05.007_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2017.10.001","article-title":"Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia","volume":"109","author":"Bossi","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.05.007_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dyebinding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2019.05.007_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.mp.4001404","article-title":"Assessment of a prepulse inhibition deficit in a mutant mouse lacking mglu5 receptors","volume":"9","author":"Brody","year":"2004","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.nbd.2019.05.007_bb0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections","volume":"2014","author":"Cardiff","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"issue":"11","key":"10.1016\/j.nbd.2019.05.007_bb0080","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"4 Suppl 2","key":"10.1016\/j.nbd.2019.05.007_bb0085","first-page":"S54","article-title":"Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease","volume":"47","author":"Cleveland","year":"1996","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.nbd.2019.05.007_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0166-2236(99)01445-9","article-title":"Shaping excitation at glutamatergic synapses","volume":"22","author":"Conti","year":"1999","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2019.05.007_bb0095","first-page":"593","article-title":"crv4, a mouse model for human ataxia associated with kyphoscoliosis caused by an mRNA splicing mutation of the metabotropic glutamate receptor 1 (Grm1)","volume":"18","author":"Conti","year":"2006","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.nbd.2019.05.007_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2011.01.013","article-title":"A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death","volume":"42","author":"D'Antoni","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.nbd.2019.05.007_bb0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.23868","article-title":"G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration","volume":"73","author":"Degos","year":"2013","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1096\/fj.10-163147","article-title":"A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors","volume":"25","author":"Doumazane","year":"2011","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21404","article-title":"Amyotrophic lateral sclerosis \u2013 evolutionary and other perspectives","volume":"40","author":"Eisen","year":"2009","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.nbd.2019.05.007_bb0125","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motorneuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2019.05.007_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuropharm.2012.05.018","article-title":"Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis","volume":"66","author":"Giribaldi","year":"2013","journal-title":"Neuropharmacology."},{"issue":"5166","key":"10.1016\/j.nbd.2019.05.007_bb0135","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.nbd.2019.05.007_bb0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.nbd.2019.05.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070415","article-title":"MGluR5 ablation in cortical glutamatergic neurons increases novelty-induced locomotion","volume":"8","author":"Jew","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2019.05.007_bb0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2015.09.019","article-title":"Excitotoxicity in ALS: overstimulation, or overreaction?","volume":"1","author":"King","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.05.007_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.2005.tb00034.x","article-title":"Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit","volume":"1053","author":"Kuner","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.05.007_bb0160","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2015.14054","article-title":"Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis","volume":"145","author":"Laferriere","year":"2015","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.nbd.2019.05.007_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/718987","article-title":"Glial cells in amyotrophic lateral sclerosis","volume":"2011","author":"Lasiene","year":"2011","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.nbd.2019.05.007_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2018.09.021","article-title":"Riluzole attenuates the efficacy of glutamatergic transmission by interfering with the size of the readily releasable neurotransmitter pool","volume":"143","author":"Lazarevic","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.nbd.2019.05.007_bb0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5607\/en.2016.25.5.233","article-title":"Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS","volume":"25","author":"Lee","year":"2016","journal-title":"Exp. Neurobiol."},{"issue":"13","key":"10.1016\/j.nbd.2019.05.007_bb0180","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","article-title":"Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-termpotentiation (LTP) butnormal CA3 LTP","volume":"17","author":"Lu","year":"1997","journal-title":"J. Neurosci."},{"issue":"49","key":"10.1016\/j.nbd.2019.05.007_bb0185","doi-asserted-by":"crossref","DOI":"10.3791\/2376","article-title":"Assessment of motor balance and coordination in mice using the balance beam","volume":"10","author":"Luong","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00406-016-0728-z","article-title":"Altered expression of schizophrenia-related genes in mice lacking mglu5 receptors","volume":"268","author":"Luoni","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2019.05.007_bb0195","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/hmg\/ddr513","article-title":"The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals","volume":"21","author":"Martorana","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.05.007_bb0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1471-4159.2010.06628.x","article-title":"In-vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1\/G93A(+) mouse model of amyotrophic lateral sclerosis","volume":"113","author":"Milanese","year":"2010","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.nbd.2019.05.007_bb0205","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-4159.2010.07155.x","article-title":"Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis","volume":"116","author":"Milanese","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.05.007_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2013.11.006","article-title":"Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"64","author":"Milanese","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.05.007_bb0215","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.nbd.2014.12.004","article-title":"Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis","volume":"74","author":"Milanese","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0173(98)00049-6","article-title":"Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration","volume":"29","author":"Morrison","year":"1999","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.nbd.2019.05.007_bb0225","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuropharm.2008.06.056","article-title":"Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings","volume":"55","author":"Musante","year":"2008","journal-title":"Neuropharmacology."},{"issue":"4","key":"10.1016\/j.nbd.2019.05.007_bb0230","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.neures.2006.12.014","article-title":"Metabotropic glutamate receptor subtype-1 is essential for motor coordination in the adult cerebellum","volume":"57","author":"Nakao","year":"2007","journal-title":"Neurosci. Res."},{"issue":"7\u20138","key":"10.1016\/j.nbd.2019.05.007_bb0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside","volume":"60","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology."},{"issue":"20","key":"10.1016\/j.nbd.2019.05.007_bb0240","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/pmic.201500400","article-title":"Group I metabotropic glutamate receptors 1 and 5 form a protein complex in mouse hippocampus and cortex","volume":"16","author":"Pandya","year":"2016","journal-title":"Proteomics."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.410280105","article-title":"Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebro spinal fluid","volume":"28","author":"Perry","year":"1990","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2019.05.007_bb0250","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1172\/JCI82693","article-title":"Emerging mechanisms of molecular pathology in ALS","volume":"125","author":"Peters","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-140068","article-title":"Characterization of the contribution of genetic background and gender to disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis","volume":"2","author":"Pfohl","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"issue":"3","key":"10.1016\/j.nbd.2019.05.007_bb0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1568007023339328","article-title":"The metabotropic glutamate receptors: structure, activation mechanism and pharmacology","volume":"1","author":"Pin","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.05.007_bb0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fphar.2016.00295","article-title":"Presynaptic release-regulating mGlu1 receptors in central nervous system","volume":"7","author":"Pittaluga","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.nbd.2019.05.007_bb0275","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bjp.0705142","article-title":"Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis","volume":"138","author":"Raiteri","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.nbd.2019.05.007_bb0280","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuropharm.2003.11.025","article-title":"Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis","volume":"46","author":"Raiteri","year":"2004","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.nbd.2019.05.007_bb0285","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s12035-015-9216-0","article-title":"Support of nerve conduction by respiring myelin sheath: role of connexons","volume":"53","author":"Ravera","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.nbd.2019.05.007_bb0290","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/cdd.2008.99","article-title":"Focal degeneration of astrocytes in amyotrophic lateral sclerosis","volume":"15","author":"Rossi","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2019.05.007_bb0295","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/cercor\/bhs200","article-title":"Compensatory molecular and functional mechanisms in nervous system of the grm1(crv4) mouse lacking the mGlu1 receptor: a model for motor coordination deficits","volume":"23","author":"Rossi","year":"2013","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0300","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410280106","article-title":"Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis","volume":"28","author":"Rothstein","year":"1990","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.05.007_bb0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.brainres.2010.10.048","article-title":"SK-PC-B70M alleviates neurologic symptoms in G93A-SOD1 amyotrophic lateral sclerosis mice","volume":"1368","author":"Seo","year":"2011","journal-title":"Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2019.05.007_bb0315","doi-asserted-by":"crossref","first-page":"I17","DOI":"10.1007\/BF03161151","article-title":"Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis","volume":"247","author":"Shaw","year":"2000","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/neur.1995.0026","article-title":"CSF and plasma amino acid levels in motorneuron disease: elevation of CSF glutamate in a subset of patients","volume":"4","author":"Shaw","year":"1995","journal-title":"Neurodegeneration."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00661-X","article-title":"Glutamate levels in cerebro spinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients","volume":"193","author":"Spreux-Varoquaux","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0330","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1074\/jbc.M109.031674","article-title":"Adaptive modifications in the calpain\/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis","volume":"285","author":"Stifanese","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0335","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3565(24)35306-6","article-title":"Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area","volume":"292","author":"Swanson","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.nbd.2019.05.007_bb0340","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbadis.2014.02.009","article-title":"Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis","volume":"1842","author":"Tan","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.nbd.2019.05.007_bb0345","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jnr.20715","article-title":"Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a non competitive antagonist ameliorates the progression of amyotrophic lateral sclerosis-like disease","volume":"83","author":"Tortarolo","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2019.05.007_bb0350","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2119\/molmed.2011.00498","article-title":"Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis","volume":"18","author":"Uccelli","year":"2012","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0355","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0091-3057(02)00835-3","article-title":"Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy","volume":"73","author":"Valerio","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"37","key":"10.1016\/j.nbd.2019.05.007_bb0360","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0705046104","article-title":"Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity","volume":"104","author":"Van Damme","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2019.05.007_bb0365","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(00)00414-7","article-title":"Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons","volume":"180","author":"Van Den Bosch","year":"2000","journal-title":"J. Neurol. Sci."},{"issue":"11\u221212","key":"10.1016\/j.nbd.2019.05.007_bb0370","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","article-title":"The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis","volume":"1762","author":"Van Den Bosch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.nbd.2019.05.007_bb0375","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/hmg\/ddq463","article-title":"Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice","volume":"20","author":"Wang","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.nbd.2019.05.007_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017947","article-title":"Disease-related changes in the cerebro spinal fluid metabolome in amyotrophic lateral sclerosis detected by GC\/TOFMS","volume":"6","author":"Wuolikainen","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nbd.2019.05.007_bb0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119301214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119301214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:53:30Z","timestamp":1778576010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119301214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":77,"alternative-id":["S0969996119301214"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.05.007","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}